Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy

Allergan

Status: Completed

Conditions: Vitrectomy

Treatments: Procedure: Pars Plana Vitrectomy

Study type: Observational

Funder types: Industry

Identifiers

NCT01319318

GMA-OZU-10-017

Details and patient eligibility

About

This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.

Enrollment: 25 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Require pars plana vitrectomy in at least 1 eye
• Best corrected visual acuity in the study eye between 20/400 and 20/40

Exclusion criteria

• Use of any NSAIDs (topical or systemic) within 14 days
• Use of topical or systemic steroids within 30 days
• Active eye infection in either eye
• Any eye surgery within 6 months
• Prior pars plana vitrectomy, YAG capsulotomy or uveitis

Trial design

25 participants in 1 patient group

Pars Plana Vitrectomy

Description:

Pars plana vitrectomy performed in study eye on Day 0.

Treatment:

Procedure: Pars Plana Vitrectomy